about
Ocular and central nervous system lymphoma: clinical features and diagnosis[Birdshot retinochoroidopathy: Key messages].Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.[Current status of retinal detachment in AIDS patients]EULAR recommendations for the management of Behçet disease.Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.Clinical features, treatment methods, and evolution of birdshot chorioretinopathy in 5 different families.Tocilizumab in severe and refractory non-infectious uveitis.Primary intraocular lymphoma: diagnosis and differential diagnosis.Cytomegalovirus: virological facts for clinicians.CMV retinitis in the era of HAART.The future of primary intraocular lymphoma (retinal lymphoma).[Susac syndrome].Ocular tuberculosis.Ocular sarcoidosis.Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis.Testing ocular fluids in uveitis.PCR-based detection of Toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosis.Polymerase chain reaction analysis of aqueous humour samples in necrotising retinitis.Oculorenal manifestations in systemic autoimmune diseases.Foveal Serous Retinal Detachment in Juvenile Idiopathic Arthritis-associated Uveitis.Interplay between innate and adaptive immunity in the development of non-infectious uveitisRabbit hunter uveitis: case report of tularemia uveitis.IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma.Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.Choroidal and adnexal extranodal marginal zone B-cell lymphoma: presentation, imaging findings, and therapeutic management in a series of nine cases.Relevance of animal models to human uveitis.Animal models of intraocular lymphomas.Cataract surgery in childhood uveitis.Intraocular detection of Bartonella henselae in a patient with HLA-B27 uveitis.Deep sclerectomy and trabeculectomy in uveitic glaucoma.Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.Systemic treatment of sarcoidosis.High prevalence of fastidious bacteria in 1520 cases of uveitis of unknown etiology.Understanding uveitis: the impact of research on visual outcomes.Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.Use of fluorescein angiography in the diagnosis and management of uveitis.Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies.Therapy of ocular Behçet disease.
P50
Q28206092-3103E706-7902-4657-99B1-8450C4EB6962Q30249360-BD67B6C0-573F-4816-9DE9-9868DA7F286FQ30659915-9E24B410-B8B6-4D32-AEC0-1FDE03DA777CQ30671494-36B7DA5E-F90E-48A2-89AF-29AF99DF432DQ30977607-DE79BC19-433E-4B69-BEB2-64B1CDBCC272Q33317927-55F918D0-85BF-45A1-8D0C-DAA915920465Q33329054-FEB8E325-5C14-4F73-B6C9-938161A05BC3Q33416260-DFD3D215-2481-4ABE-97E0-898DDBDE9E7FQ33417913-6A9EAE60-3294-4292-8EA7-54B3BE1939A3Q33479622-3E450725-051A-4709-9BFA-1CAEBB2F487EQ33804031-B0ADB37C-7710-4463-8AC7-A5647B6E113DQ33804055-C5586EA7-9828-4305-96E3-AF9FFF8380B2Q33950795-DA80169C-2ABD-4EE8-8F31-82A8708202AEQ34109038-3B39DDE8-32E0-4D2D-9970-C55606845EFFQ34120539-3F6A855F-8590-4994-A8CD-3977503100D7Q34275700-33EA1097-4244-46BC-9130-7B5FADCA6271Q34583801-4C26B377-6F60-4170-984C-3346F1D9BC50Q34998771-D52BBC9D-DEE7-4F1A-9D56-0B6F49F777F4Q35036024-9A393959-E106-46DA-971D-731C080288CDQ35590463-CEE480EB-8605-4968-AA32-ED5021A9A88FQ35642242-CA2949DE-8088-4001-91A6-585926BB1AD4Q35690424-9325EFBB-CE8B-4F6A-A6AD-3C49584C1B5AQ35784059-BB60074F-AC55-475B-A10A-2364C2B1DE93Q36120290-3CAFB811-E481-4485-9350-185C6318ED14Q36145665-C8DD1E7A-A4B6-4757-ADDF-6DC857E20F7AQ36778276-9F649A97-8E1E-4F5E-BA2E-86AE5B1A9619Q37005945-D78A700A-ABA6-47F0-A7EE-631657726F03Q37141740-6FAA7AA7-E4E9-463F-AF34-1C492F4CF40DQ37141743-679E87ED-7010-4363-9070-B053DA9229ADQ37223401-2B7C1A71-E17D-46BB-B013-D5300F49C846Q37420396-03C2EF86-BAB0-4720-B33F-46BFF6000F5EQ37448166-22226006-D19E-494B-B36F-1C244DF69FB4Q37830790-D6549770-0D64-4BB5-B1B5-F884CFA62BAFQ37856272-13E2F4BF-80DF-4120-9669-F20D17BEE47AQ37857376-14A12533-9D89-423C-9CF4-FF303B2F8579Q37909585-09F2A899-6D8E-4C70-87C6-7A3F6C1189C6Q37995987-E4F60163-D1F6-410C-A4AB-C11ED57435D5Q38041342-D601FDB7-9877-49B6-99FC-B800E80ED8B3Q38087452-E1DDC8C5-0C0C-4D83-ADED-30C75C19F81EQ38174652-37C4873C-1226-43E7-94E8-FA318640CE8B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bahram Bodaghi
@ast
Bahram Bodaghi
@en
Bahram Bodaghi
@es
Bahram Bodaghi
@sl
type
label
Bahram Bodaghi
@ast
Bahram Bodaghi
@en
Bahram Bodaghi
@es
Bahram Bodaghi
@sl
prefLabel
Bahram Bodaghi
@ast
Bahram Bodaghi
@en
Bahram Bodaghi
@es
Bahram Bodaghi
@sl
P214
P244
P106
P213
0000 0000 7128 5315
P214
P244
n2019180305
P31
P496
0000-0002-0962-5301
P7859
lccn-n2019180305